Search anything and hit enter
  • Teams
  • Members
  • Projects
  • Events
  • Calls
  • Jobs
  • publications
  • Software
  • Tools
  • Network
  • Equipment

A little guide for advanced search:

  • Tip 1. You can use quotes "" to search for an exact expression.
    Example: "cell division"
  • Tip 2. You can use + symbol to restrict results containing all words.
    Example: +cell +stem
  • Tip 3. You can use + and - symbols to force inclusion or exclusion of specific words.
    Example: +cell -stem
e.g. searching for members in projects tagged cancer
Search for
Count
IN
OUT
Content 1
  • member
  • team
  • department
  • center
  • program_project
  • nrc
  • whocc
  • project
  • software
  • tool
  • patent
  • Administrative Staff
  • Assistant Professor
  • Associate Professor
  • Clinical Research Assistant
  • Clinical Research Nurse
  • Clinician Researcher
  • Department Manager
  • Dual-education Student
  • Full Professor
  • Honorary Professor
  • Lab assistant
  • Master Student
  • Non-permanent Researcher
  • Nursing Staff
  • Permanent Researcher
  • Pharmacist
  • PhD Student
  • Physician
  • Post-doc
  • Prize
  • Project Manager
  • Research Associate
  • Research Engineer
  • Retired scientist
  • Technician
  • Undergraduate Student
  • Veterinary
  • Visiting Scientist
  • Deputy Director of Center
  • Deputy Director of Department
  • Deputy Director of National Reference Center
  • Deputy Head of Facility
  • Director of Center
  • Director of Department
  • Director of Institute
  • Director of National Reference Center
  • Group Leader
  • Head of Facility
  • Head of Operations
  • Head of Structure
  • Honorary President of the Departement
  • Labex Coordinator
Content 2
  • member
  • team
  • department
  • center
  • program_project
  • nrc
  • whocc
  • project
  • software
  • tool
  • patent
  • Administrative Staff
  • Assistant Professor
  • Associate Professor
  • Clinical Research Assistant
  • Clinical Research Nurse
  • Clinician Researcher
  • Department Manager
  • Dual-education Student
  • Full Professor
  • Honorary Professor
  • Lab assistant
  • Master Student
  • Non-permanent Researcher
  • Nursing Staff
  • Permanent Researcher
  • Pharmacist
  • PhD Student
  • Physician
  • Post-doc
  • Prize
  • Project Manager
  • Research Associate
  • Research Engineer
  • Retired scientist
  • Technician
  • Undergraduate Student
  • Veterinary
  • Visiting Scientist
  • Deputy Director of Center
  • Deputy Director of Department
  • Deputy Director of National Reference Center
  • Deputy Head of Facility
  • Director of Center
  • Director of Department
  • Director of Institute
  • Director of National Reference Center
  • Group Leader
  • Head of Facility
  • Head of Operations
  • Head of Structure
  • Honorary President of the Departement
  • Labex Coordinator
Search
Go back
Scroll to top
Share
© Research
Group

Cystic Fibrosis and Bronchial Diseases

Department of Global Health

About

Cystic fibrosis (CF) is a lethal autosomal, recessive inherited disease that commonly affects Caucasians. This disease is due to mutation of CF transmembrane conductance regulator (CFTR) gene that encodes a protein channel in epithelial cells where it regulates the luminal secretion of chloride and water transport. Pulmonary infections in CF are a major problem that determines the life span and life quality of patients. Indeed, mutations of CFTR cause depletion of airway surface liquid leading to mucus dehydration and stagnation, which provide appropriate niche for infection by opportunistic bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. These infections leads to chronic airways inflammation which evolves progressively leading ultimately to lung injury and patients death. Most of bacteria that infect CF patient airways are difficult to treat by conventional antibiotics due to increased antibiotic resistance. Thus, airways infections by these opportunistic bacteria, associated to abnormal bronchial mucus and chronic inflammation are the major problems of CF patients that need to be treated.

Innate immunity allows detecting few highly conserved structures present in pathogens. These structures are referred to pathogen-associated molecular patterns (PAMPs), and receptors that recognize them are called pattern-recognition receptors (PRR) including Toll-Like Receptors (TLRs). Airways epithelial cells (AECs) and alveolar macrophages (AMs) are the first host cells to sense pathogens in airways and produce inflammatory mediators together with antimicrobial peptides (AMPs) that participate to pathogens elimination.  Nonetheless, uncontrolled immune response leads to cellular damage and eventually to host death. Airways inflammation involves a variety of mediators including cytokines and eicosanoids. The latter are produced through the activation of a host enzyme named cytosolic phospholipase A2α (cPLA2α). The latter is a ubiquitous enzyme present in host cells where it hydrolyses phospholipids at the sn-2 position resulting in the release of arachidonic acid (AA) whose conversion by LOXs leads to the production of pro-inflammatory leukotriens, such as LTB4. AA is also converted by cyclooxygenases (COXs) into anti-inflammatory prostaglandins such as PGE2. AMPs are ubiquitous, gene-encoded natural “antibiotics” including cationic peptides, defensins and secreted phospholipases A2 (sPLA2, different from cPLA2) that have gained recent attention in the search for new antimicrobials to combat infectious disease. Among sPLA2 family, sPLA2-IIA is the most potent mammalian bactericidal agent against Gram-positive bacteria while having minimal side effect on host cells.

The major projects of our team are : i) identify the strategies by which P. aeruginosa and S. aureus subvert immunity to infect airways of CF patients, ii) examine the mechanisms by which abnormal bronchial mucus facilitates bacterial colonization , iii) examine  the role of the host immunity, including endogenous AMPs such as sPLA2-IIA and LL-37, in the control of S. aureus and P. aeruginosa proliferatios in airways, iv) and identify therapeutic tools that may help to control airways infection and mucus production.

___________________________________________________________________________________________

Former Members

2000
2000
Name
Position
2016
2019
Yongzheng Wu
Group Leader
2016
2019
Laurent Guillemot
Technician

Projects

Fundings

Partners

Publications

Download